|Articles|November 1, 2012
- Pharmaceutical Executive-11-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2012
Pharm Exec's 2013 Pipeline Report
Advertisement
Articles in this issue
about 13 years ago
Europe's Trust Gapabout 13 years ago
Who Pays for Specialty Medicines?about 13 years ago
OTC Crunch Time in Californiaabout 13 years ago
Prix Galien: Night at the Museumabout 13 years ago
Real World Insightsabout 13 years ago
Simple Questions for Spainabout 13 years ago
Market Access Roadmapabout 13 years ago
Pharm Exec's 2013 Pipeline Reportabout 13 years ago
Country Report: Czech RepublicNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
